Disposition and metabolism of isoeugenol in the male Fischer 344 rat

Food and Chemical Toxicology

Volumn 40, Issue 12, 2002, Pages 1757-1765

  Badger, D A ^a   Smith, R L ^a   Bao, J ^a   Kuester, R K ^a   Sipes, I G ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Disposition; Isocugenol; Metabolism; Phase II metabolites

Indexed keywords

ISOEUGENOL;

ARTICLE; BLOOD; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISPOSITION; DRUG EXCRETION; DRUG METABOLISM; FECES; MALE; NONHUMAN; RADIOACTIVITY; RAT; RAT STRAIN; URINARY EXCRETION;

ADMINISTRATION, ORAL; ANIMALS; CARBON RADIOISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EUGENOL; FECES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, INBRED F344; TISSUE DISTRIBUTION;

EID: 0036888067     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(02)00183-7     Document Type: Article

References (23)

1. Benedetti M.S., Malnoe A., Broillet A.L. Absorption, metabolism and excretion of safrole in the rat and man. Toxicology. 7(1):1977;69-83.
2. Bertrand F., Basketter D.A., Roberts D.W., Lepoittevin J. Skin sensitization to eugenol and isoeugenol in mice. possible metabolic pathways involving ortho-quinone and quinone methide intermediates Chemical Research Toxicology. 10:1997;335-343.
3. Birnbaum L.S., Decad G.M., Matthews H.B. Disposition and excretion of 2,3,7,8-tetrachlorodibenzofuran in the rat. Toxicology and Applied Pharmacology. 55(2):1980;342-352.
4. Boberg E.W., Miller E.C., Miller J.A., Poland A., Liem A. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver. Cancer Research. 43(11):1983;5163-5173.
5. Burkey J.L., Sauer J.-M, McQueen C.A., Sipes I.G. Cytotoxicity and genotoxicity of methyleugenol and related congeners - a mechanism of activation for methyleugenol. Mutation Research. 453:2000;25-33.
6. Chemical Carcinogenesis Research Information System (CCRIS), On-line Database: Estragole, February 1991
7. Fennell T.R., Miller J.A., Miller E.C. Characterization of the biliary and urinary glutathione and acetylcystein metabolites of the hepatic carcinogen 1′-hydroxysafrole and its 1′-oxo metabolite in rats and mice. Cancer Research. 44:1984;3231-3240.
8. Fischer I.U., VonUnruh G.E., Dengler H.J. The metabolism of eugenol in man. Xenobiotica. 20(2):1990;209-222.
9. IARC. 1976. Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans. Vol. 10. Some Naturally Occurring Substances. International Agency for Research on Cancer: Lyon. pp.231-241.
10. Jimbo Y., Ishihara M., Osamura H., Takano M., Uhara M. Influence of vehicles on penetration through human epidermis of benzyl alcohol, isoeugenol and methyl isoeugenol. Journal of Dermatology. 10:1983;241-250.
11. Klaassen, C.D., 2001. Casarett and Doull's Toxicology: The Basic Science of Poisons, Sixth Ed. McGraw-Hill, New York.
12. Marshall A.D., Caldwell J. Lack of influence of modulators of epoxide metabolism on the genotoxicity of trans-anethole in freshly isolated rat hepatocytes assessed with the unscheduled DNA synthesis assay. Food and Chemical Toxicology. 34:1996;337-345.
13. Matthews H.B., Anderson M.W. The distribution and excretion of 2,4,5,2′,5′-pentachlorobiphenyl in the rat. Drug Metabolism and Disposition. 3:1975;211-219.
14. Miller E.C., Swanson A.B., Phillips D.H., Fletcher T.L., Liem A., Miller J.A. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Research. 43:1983;1124-1134.
15. Miller J.A., Miller E.C. The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens. recent results with ethyl carbamate and the spice flavors safrole and estragole British Journal of Cancer. 48:1983;1-15.
16. National Toxicology Program (NTP), February, 1989. Abstracts of Subchronic Gavage Studies in Fischer-344 Rats and B6C3F1 Mice.
17. Newberne P., Smith R.L., Doull J., Goodman J.I., Munro I.C., Portoghese P.S., Wagner B.M., Weil C.S., Woods L.A., Adams T.B., Lucas C.D., Ford R.A. The FEMAGRAS assessment of trans-anethole used as a flavouring substance. Flavour and Extract Manufacturer's Association. Food and Chemical Toxicology. 37(7):1999;789-811.
18. Peters M.M., Caldwell J. Studies on trans-cinnamaldehyde. The influence of dose size and sex on its disposition in the rat and mouse. Food and Chemical Toxicology. 32(10):1994;869-876.
19. Sutton J.D., Sangster S.A., Caldwell J. Dose-dependent variation in the disposition of eugenol in the rat. Biochemical Pharmacology. 34(3):1985;465-466.
20. Thompson D.C., Thompson J.A., Sugumaran M., Moldeus P. Biological and toxicological consequences of quinone methide formation. ChemicoBiological Interactions. 86:1992;129-162.
21. Thompson D.C., Barhoumi R., Burghardt R.C. Comparative toxicity of eugenol and its quinone methide metabolite in cultured liver cells using kinetic fluorescence bioassays. Toxicology and Applied Pharmacology. 149:1998;55-63.
22. Tsai R., Carrupt P., Testa B., Caldwell J. Structure-genotoxicity relationships of allylbenzenes and propenylbenzenes. A quantum chemical study Chemical Research in Toxicology. 7:1994;73-76.
23. 13C nuclear magnetic resonance spectroscopy. Drug Metabolism and Disposition. 20:1992;665-672.